Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

teleflex inc. - TFX

TFX

Close Chg Chg %
121.64 0.42 0.35%

Closed Market

122.06

+0.42 (0.35%)

Volume: 400.31K

Last Updated:

Dec 31, 2025, 3:59 PM EDT

Trade Now

Company Overview: teleflex inc. - TFX

TFX Key Data

Open

$121.32

 Day Range

120.31 - 122.25

52 Week Range

102.63 - 185.84

 Market Cap

$5.39B

Shares Outstanding

44.19M

 Public Float

43.86M

Beta

0.93

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$7.35

Yield

111.82%

 Dividend

$0.34

EX-DIVIDEND DATE

Nov 14, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

725.45K

  

TFX Performance

1 Week
 
 -0.59%
 
1 Month
 
 1.28%
 
3 Months
 
 -6.77%
 
1 Year
 
 -31.43%
 
5 Years
 
 -70.35%
 

TFX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 15
Full Ratings ➔

About teleflex inc. - TFX

Teleflex, Inc. engages in the provision of medical technology products. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia, and Original Equipment Manufacturer and Development Services (OEM). The Americas, EMEA, and Asia segments are involved in the design, manufacture, and distribution of medical devices primarily used in critical care and surgical applications and generally serve two end-markets: hospitals and healthcare providers, and home health. The OEM segment refers to the design, manufacture, and supply of devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.

TFX At a Glance

Teleflex, Inc.
550 East Swedesford Road
Wayne, Pennsylvania 19087
Phone 1-610-225-6800 Revenue 3.05B
Industry Medical Specialties Net Income 69.68M
Sector Health Technology 2024 Sales Growth 2.449%
Fiscal Year-end 12 / 2025 Employees 14,100
View SEC Filings

TFX Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 120.297
Price to Sales Ratio 2.751
Price to Book Ratio 2.001
Price to Cash Flow Ratio 13.18
Enterprise Value to EBITDA 11.744
Enterprise Value to Sales 3.232
Total Debt to Enterprise Value 0.18

TFX Efficiency

Revenue/Employee 216,122.27
Income Per Employee 4,941.489
Receivables Turnover 6.632
Total Asset Turnover 0.417

TFX Liquidity

Current Ratio 2.265
Quick Ratio 1.341
Cash Ratio 0.47

TFX Profitability

Gross Margin 56.091
Operating Margin 18.509
Pretax Margin 2.477
Net Margin 2.286
Return on Assets 0.959
Return on Equity 1.609
Return on Total Capital 1.16
Return on Invested Capital 1.149

TFX Capital Structure

Total Debt to Total Equity 41.429
Total Debt to Total Capital 29.293
Total Debt to Total Assets 24.97
Long-Term Debt to Equity 38.686
Long-Term Debt to Total Capital 27.353
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Teleflex Inc. - TFX

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
2.81B 2.79B 2.97B 3.05B
Sales Growth
+10.74% -0.66% +6.57% +2.45%
Cost of Goods Sold (COGS) incl D&A
1.26B 1.23B 1.33B 1.34B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
237.36M 230.59M 242.12M 274.60M
Depreciation
71.76M 66.50M 68.14M 76.93M
Amortization of Intangibles
165.60M 164.09M 173.97M 197.67M
COGS Growth
+3.83% -2.29% +7.72% +0.80%
Gross Income
1.55B 1.56B 1.65B 1.71B
Gross Income Growth
+17.08% +0.67% +5.66% +3.78%
Gross Profit Margin
+55.11% +55.85% +55.37% +56.09%
2021 2022 2023 2024 5-year trend
SG&A Expense
977.13M 1.01B 1.07B 1.15B
Research & Development
130.84M 153.82M 154.35M 161.67M
Other SG&A
846.29M 857.10M 918.57M 983.57M
SGA Growth
+19.42% +3.46% +6.13% +6.74%
Other Operating Expense
- - - -
-
Unusual Expense
48.52M 58.60M 27.00M 280.29M
EBIT after Unusual Expense
522.80M 489.23M 547.11M 283.74M
Non Operating Income/Expense
112.93M 31.83M 3.03M (105.69M)
Non-Operating Interest Income
1.33M 912.00K 12.78M 8.01M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
76.27M 75.14M 116.13M 102.58M
Interest Expense Growth
-5.84% -1.47% +54.54% -11.67%
Gross Interest Expense
76.27M 75.14M 116.13M 102.58M
Interest Capitalized
- - - -
-
Pretax Income
559.47M 445.92M 434.01M 75.48M
Pretax Income Growth
+56.39% -20.30% -2.67% -82.61%
Pretax Margin
+19.91% +15.98% +14.59% +2.48%
Income Tax
74.35M 83.00M 76.44M 5.32M
Income Tax - Current - Domestic
151.31M 41.55M 59.98M 91.22M
Income Tax - Current - Foreign
35.40M 56.44M 30.41M 43.83M
Income Tax - Deferred - Domestic
(102.20M) (17.41M) (18.96M) (113.65M)
Income Tax - Deferred - Foreign
(10.15M) 2.43M 5.01M (16.09M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
485.12M 362.92M 357.57M 70.16M
Minority Interest Expense
- - - -
-
Net Income
485.12M 362.92M 357.57M 70.16M
Net Income Growth
+44.47% -25.19% -1.47% -80.38%
Net Margin Growth
+17.27% +13.00% +12.02% +2.30%
Extraordinaries & Discontinued Operations
255.00K 223.00K (1.24M) (487.00K)
Discontinued Operations
255.00K 223.00K (1.24M) (487.00K)
Net Income After Extraordinaries
485.37M 363.14M 356.33M 69.68M
Preferred Dividends
- - - -
-
Net Income Available to Common
485.37M 363.14M 356.33M 69.67M
EPS (Basic)
10.377 7.7432 7.5845 1.4876
EPS (Basic) Growth
+43.86% -25.38% -2.05% -80.39%
Basic Shares Outstanding
46.77M 46.90M 46.98M 46.84M
EPS (Diluted)
10.2341 7.6759 7.5327 1.4795
EPS (Diluted) Growth
+44.32% -25.00% -1.87% -80.36%
Diluted Shares Outstanding
47.43M 47.31M 47.30M 47.09M
EBITDA
808.68M 778.43M 816.23M 838.64M
EBITDA Growth
+10.54% -3.74% +4.86% +2.75%
EBITDA Margin
+28.78% +27.89% +27.44% +27.52%

Snapshot

Average Recommendation HOLD Average Target Price 130.50
Number of Ratings 15 Current Quarters Estimate 3.115
FY Report Date 03 / 2026 Current Year's Estimate 15.168
Last Quarter’s Earnings 3.809 Median PE on CY Estimate N/A
Year Ago Earnings 14.098 Next Fiscal Year Estimate 16.55
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 10 10 12 10
Mean Estimate 3.12 3.80 15.17 16.55
High Estimates 3.30 4.41 16.78 18.88
Low Estimate 2.91 3.55 14.35 15.02
Coefficient of Variance 4.14 6.36 4.54 6.74

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 12 12 12
UNDERWEIGHT 2 2 1
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Teleflex Inc. - TFX

Date Name Shares Transaction Value
Apr 4, 2025 Thomas E. Powell Executive Vice President & CFO 20,812 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 0.00
Apr 4, 2025 Thomas E. Powell Executive Vice President & CFO 21,467 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $140.3 per share 3,011,820.10
Mar 7, 2025 Daniel V. Logue CVP, General Counsel & Secty 13,387 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Daniel V. Logue CVP, General Counsel & Secty 14,972 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 John R. Deren Corp. VP & CAO 18,896 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 John R. Deren Corp. VP & CAO 4,588 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Cameron P. Hicks Corp. VP & Chief HR Officer 10,040 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Cameron P. Hicks Corp. VP & Chief HR Officer 11,408 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Jay White CVP & Pres, Global Commercial 13,387 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Jay White CVP & Pres, Global Commercial 7,761 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Liam J. Kelly Chairman, President & CEO; Director 71,983 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 Liam J. Kelly Chairman, President & CEO; Director 43,767 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 James Winters Corp VP, Mfg and Supply 13,387 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 7, 2025 James Winters Corp VP, Mfg and Supply 5,307 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 24, 2025 Liam J. Kelly Chairman, President & CEO; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 24, 2025 Liam J. Kelly Chairman, President & CEO; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 24, 2025 Liam J. Kelly Chairman, President & CEO; Director 63,556 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $123.04 per share 7,819,930.24
Feb 24, 2025 Stephen K. Klasko Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 24, 2025 Stephen K. Klasko Director 7,976 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $174.82 per share 1,394,364.32
Feb 24, 2025 Daniel V. Logue CVP, General Counsel & Secty N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Teleflex Inc. in the News